Drug
Marimastat clinical trials
- studies test it
- 5
- open now
- 1
- in phase 3
- 3
- first study started
- 1996
Keep track of what changes. Save the marimastat studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
4 studies that test it; most in 1997 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1997 | 2 |
| 2000 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 4
Eastern Cooperative Oncology Group (1) · NCIC Clinical Trials Group (1) · ILEX Oncology Services, Incorporated (1) · Boston Children's Hospital (1) · Liverpool School of Tropical Medicine (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses marimastat is read from its arms, and is right about nine times in ten.
Testing it · 5
- Trial of Oral Community SVMP INhibitors for SnakebiteNot yet recruitingPhase 2Liverpool School of Tropical MedicineNCT07500233Written as marimastat
- Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following ChemotherapyCompletedPhase 3Eastern Cooperative Oncology GroupNCT00003010Written as marimastat
- Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung CancerCompletedPhase 3NCIC Clinical Trials GroupNCT00003011Written as marimastat
- Marimastat in Treating Patients With Stage III Non-small Cell Lung CancerCompletedPhase 3ILEX Oncology Services, IncorporatedNCT00002911Written as marimastat
- Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.CompletedPhase 1Boston Children's HospitalNCT00261391Written as Marimastat
Codes
What other systems call marimastat · ClinicalTrials.gg INT003921
- MeSH (NLM) C100342marimastatConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) D5EQV23TDSMARIMASTATConfirmed FDA, NLM, Wikidata
- Wikidata Q6763659marimastatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1652MarimastatOne source FDA
- DrugBank DB00786One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C100342 | marimastat | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | D5EQV23TDS | MARIMASTAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6763659 | marimastat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1652 | Marimastat | One source FDA |
| DrugBank | DB00786 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.